Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NEFAZODONE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 150 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sanchez-Lacay, JA; Lewis-Fernandez, R; Goetz, D; Blanco, C; Salman, E; Davies, S; Liebowitz, M
      Open trial of nefazodone among Hispanics with major depression: Efficacy, tolerability, and adherence issues

      DEPRESSION AND ANXIETY
    2. Alderman, CP; Gebauer, MG; Gilbert, AL; Condon, JT
      Possible interaction of zopiclone and nefazodone

      ANNALS OF PHARMACOTHERAPY
    3. Sauer, J; Bhugra, D
      Drug treatments in post-traumatic stress disorder

      INTERNATIONAL REVIEW OF PSYCHIATRY
    4. Bryant, RA; Friedman, M
      Medication and non-medication treatments of post-traumatic stress disorder

      CURRENT OPINION IN PSYCHIATRY
    5. Garfield, DAS; Fichtner, CG; Leveroni, C; Mahableshwarkar, A
      Open trial of nefazodone for combat veterans with posttraumatic stress disorder

      JOURNAL OF TRAUMATIC STRESS
    6. Jaunay, E; Gaillac, V; Guelfi, JD
      The serotonin syndrome: what treatment and when

      PRESSE MEDICALE
    7. Rivas-Vazquez, RA
      Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders

      PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    8. Rao, DS; Geetha, S; Srinivasu, MK; Reddy, GO
      LC determination and purity evaluation of nefazodone HCl in bulk drug and pharmaceutical formulations

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    9. Ozdemir, V; Kalow, W; Okey, AB; Lam, MSM; Albers, LJ; Reist, C; Fourie, J; Posner, P; Collins, EJ; Roy, R
      Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C -> A polymorphism in intron 1 of the CYP1A2 gene: Effect of grapefruit juice and low-dose fluvoxamine

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    10. Baldwin, DS; Hawley, CJ; Mellors, K
      A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment

      JOURNAL OF PSYCHOPHARMACOLOGY
    11. Dursun, SM; Devarajan, S; Kutcher, S
      The 'Dalhousie Serotonin cocktail' for treatment-resistant major depressive disorder

      JOURNAL OF PSYCHOPHARMACOLOGY
    12. Kodesh, A; Katz, S; Lerner, AG; Finkel, B; Sigal, M
      Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder

      JOURNAL OF PSYCHOPHARMACOLOGY
    13. Butterfield, MI; Becker, ME; Connor, KM; Sutherland, S; Churchill, LE; Davidson, JRT
      Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    14. Seedat, S; Lockhat, R; Kaminer, D; Zungu-Dinwayi, N; Stein, DJ
      An open trial of citalopram in adolescents with post-traumatic stress disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    15. Wolf, R; Dykierek, P; Gattaz, WF; Maras, A; Kohnen, R; Dittmann, RW; Geuppert, M; Riemann, D; Berger, M
      Differential effects of trimipramine and fluoxetine on sleep in geriatric depression

      PHARMACOPSYCHIATRY
    16. Agelink, MW; Majewski, T; Wurthmann, C; Postert, T; Linka, T; Rotterdam, S; Klieser, E
      Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone

      JOURNAL OF AFFECTIVE DISORDERS
    17. Bickeboeller-Friedrich, J; Maurer, HH
      Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes

      THERAPEUTIC DRUG MONITORING
    18. Marangell, LB
      Switching antidepressants for treatment-resistant major depression

      JOURNAL OF CLINICAL PSYCHIATRY
    19. Shoaf, TL; Emslie, GJ; Mayes, TL
      Childhood depression: Diagnosis and treatment strategies in general pediatrics

      PEDIATRIC ANNALS
    20. Caldwell, GW; Wu, WN; Masucci, JA
      Evaluation of the absorption, excretion and metabolism of [C-14] etoperidone in man

      XENOBIOTICA
    21. Liston, HL; Markowitz, JS; Hunt, N; DeVane, CL; Boulton, DW; Ashcraft, E
      Lack of citalopram effect on the pharmacokinetics of cyclosporine

      PSYCHOSOMATICS
    22. Saper, JR; Lake, AE; Tepper, SJ
      Nefazodone for chronic daily headache prophylaxis: An open-label study

      HEADACHE
    23. Sato, T; Narita, T; Hirano, S; Kusunoki, K; Goto, M; Sakado, K; Uehara, T
      Factor validity of the temperament and character inventory in patients with major depression

      COMPREHENSIVE PSYCHIATRY
    24. Storosum, JG; van Zwieten, BJ; van den Brink, W; Gersons, BPR; Broekmans, AW
      Suicide risk in placebo-controlled studies of major depression

      AMERICAN JOURNAL OF PSYCHIATRY
    25. Silva, M; Hetem, LAB; Guimaraes, FS; Graeff, FG
      Opposite effects of nefazodone in two human models of anxiety

      PSYCHOPHARMACOLOGY
    26. Landen, M; Eriksson, O; Sundblad, C; Andersch, B; Naessen, T; Eriksson, E
      Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo

      PSYCHOPHARMACOLOGY
    27. Murck, H; Frieboes, RM; Antonijevic, IA; Steiger, A
      Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men

      PSYCHOPHARMACOLOGY
    28. Wismer, TA
      Antidepressant drug overdoses in dogs

      VETERINARY MEDICINE
    29. Laizure, SC; Cyr, M
      Nefazodone: An update

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    30. Ereshefsky, L; Dugan, D
      Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: Focus on venlafaxine

      DEPRESSION AND ANXIETY
    31. Gursky, JT; Krahn, LE
      The effects of antidepressants on sleep: A review

      HARVARD REVIEW OF PSYCHIATRY
    32. Yapp, P; Ilett, KF; Kristensen, JH; Hackett, LP; Paech, MJ; Rampono, J
      Drowsiness and poor feeding in a breast-fed infant: Association with nefazodone and its metabolites

      ANNALS OF PHARMACOTHERAPY
    33. Freire-Garabal, M; Varela, M; Riveiro, P; Balboa, J; Linares, D; Mana, P; Mayan, JM; Rey-Mendez, M; Nunez, MJ
      Effects of nefazodone on the immune system of mice

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    34. Kranzler, HR; Modesto-Lowe, V; Van Kirk, J
      Naltrexone vs. nefazodone for treatment of alcohol dependence - A placebo-controlled trial

      NEUROPSYCHOPHARMACOLOGY
    35. Findling, RL; Preskorn, SH; Marcus, RN; Magnus, RD; D'Amico, F; Marathe, P; Reed, MD
      Nefazodone pharmacokinetics in depressed children and adolescents

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    36. Rivas-Vazquez, RA; Blais, MA; Rey, GJ; Rivas-Vazquez, AA
      Sexual dysfunction associated with antidepressant treatment

      PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    37. Benson, BE; Mathiason, M; Dahl, B; Smith, K; Foley, MM; Easom, LAJ; Butler, AY
      Toxicities and outcomes associated with nefazodone poisoning: An analysis of 1,338 exposures

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    38. Armitage, R
      The effects of antidepressants on sleep in patients with depression

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    39. Rosenberg, PB; Rosse, RB; Schwartz, BL; Deutsch, SI
      Nefazodone in the adjunctive therapy of schizophrenia: An open-label exploratory study

      CLINICAL NEUROPHARMACOLOGY
    40. Mirzaian, E; Gastpar, M
      New antidepressants

      AKTUELLE NEUROLOGIE
    41. Brunello, N; Armitage, R; Feinberg, I; Holsboer-Trachsler, E; Leger, D; Linkowski, P; Mendelson, WB; Racagni, G; Saletu, B; Sharpley, AL; Turek, F; Van Cauter, E; Mendlewicz, J
      Depression and sleep disorders: Clinical relevance, economic burden and pharmacological treatment

      NEUROPSYCHOBIOLOGY
    42. Oberndorfer, S; Saletu-Zyhlarz, G; Saletu, B
      Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality

      NEUROPSYCHOBIOLOGY
    43. Berk, M; Stein, DJ; Potgieter, A; Maud, CM; Els, C; Janet, ML; Viljoen, E
      Serotonergic targets in the treatment of antidepressant induced sexual dysfunction: a pilot study of granisetron and sumatriptan

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    44. Lauterbach, EC; Abdelhamid, A; Annandale, JB
      Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: Possible relation to serotonin 5HT2a receptor blockade

      PHARMACOPSYCHIATRY
    45. Eloubeidi, MA; Gaede, JT; Swaim, MW
      Reversible nefazodone-induced liver failure

      DIGESTIVE DISEASES AND SCIENCES
    46. Pearlstein, T
      Antidepressant treatment of posttraumatic stress disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    47. Rothschild, AJ
      New directions in the treatment of antidepressant-induced sexual dysfunction

      CLINICAL THERAPEUTICS
    48. Kent, JM
      SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

      LANCET
    49. Pomeranz, HD; Lessell, S
      Palinopsia and polyopia in the absence of drugs or cerebral disease

      NEUROLOGY
    50. DeVane, CL; Markowitz, JS
      Avoiding psychotropic drug interactions in the cardiovascular patient

      BULLETIN OF THE MENNINGER CLINIC
    51. Mason, PJ; Morris, VA; Balcezak, TJ
      Serotonin syndrome - Presentation of 2 cases and review of the literature

      MEDICINE
    52. Hickie, IB
      An approach to managing depression in general practice

      MEDICAL JOURNAL OF AUSTRALIA
    53. Pullar, IA; Carney, SL; Colvin, EM; Lucaites, VL; Nelson, DL; Wedley, S
      LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone

      EUROPEAN JOURNAL OF PHARMACOLOGY
    54. Sayal, KS; Duncan-McConnell, DA; McConnell, HW; Taylor, DM
      Psychotropic interactions with warfarin

      ACTA PSYCHIATRICA SCANDINAVICA
    55. Wilson, SJ; Bell, C; Coupland, NJ; Nutt, DJ
      Sleep changes during long-term treatment of depression with fluvoxamine - a home-based study

      PSYCHOPHARMACOLOGY
    56. Dodd, S; Buist, A; Burrows, GD; Maguire, KP; Norman, TR
      Determination of nefazodone and its pharmacologically active metabolites in human blood plasma and breast milk by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    57. Romero, AS; Delgado, RG; Pena, MF
      Interaction between trazodone and carbamazepine

      ANNALS OF PHARMACOTHERAPY
    58. Mackay, FJ; Pearce, GL; Freemantle, SN; Mann, RD
      Nefazodone in community use: The results of prescription-event monitoring

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    59. Conca, A; Al-Dubai, Z; Konig, P; Beraus, W
      Combining nefazodone and midazolam during ECT

      EUROPEAN PSYCHIATRY
    60. Buysse, DJ; Kupfer, DJ; Cherry, C; Stapf, D; Frank, E
      Effects of prior fluoxetine treatment on EEG sleep in women with recurrentdepression

      NEUROPSYCHOPHARMACOLOGY
    61. Catalano, G; Catalano, MC; Tumarkin, NBB
      Nefazodone overdose: A case report

      CLINICAL NEUROPHARMACOLOGY
    62. Rotzinger, S; Bourin, M; Akimoto, Y; Coutts, RT; Baker, GB
      Metabolism of some "second"- and "fourth"-generation antidepressants: Iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    63. Markowitz, JS; DeVane, CL
      Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    64. Joffe, G; Appelberg, B; Rimon, R
      Adjunctive nefazodone in neuroleptic-treated schizophrenic patients with predominantly negative symptoms: an open prospective pilot study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    65. Taylor, D; Bodani, M; Hubbeling, A; Murray, R
      The effect of nefazodone on clozapine plasma concentrations

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    66. Hidalgo, R; Hertzberg, MA; Mellman, T; Petty, F; Tucker, P; Weisler, R; Zisook, S; Chen, S; Churchill, E; Davidson, J
      Nefazodone in post-traumatic stress disorder: results from six open-label trials

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    67. Feiger, AD; Bielski, RJ; Bremner, J; Heiser, JF; Trivedi, M; Wilcox, CS; Roberts, DL; Kensler, TT; McQuade, RD; Kaplita, SB; Archibald, DG
      Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    68. Boerner, RJ; Moller, HJ
      The importance of new antidepressants in the treatment of anxiety/depressive disorders

      PHARMACOPSYCHIATRY
    69. Poland, RE; Rao, U; Lutchmansingh, P; McCracken, JT; Lesser, IM; Edwards, C; Ott, GE; Lin, KM
      REM sleep in depression is influenced by ethnicity

      PSYCHIATRY RESEARCH
    70. Sato, T; Hirano, S; Narita, T; Kusunoki, K; Kato, J; Goto, M; Sakado, K; Uehara, T
      Temperament and character inventory dimensions as a predictor of response to antidepressant treatment in major depression

      JOURNAL OF AFFECTIVE DISORDERS
    71. Lucena, MI; Andrade, RJ; Gomez-Outes, A; Rubio, M; Cabello, MR
      Acute liver failure after treatment with nefazodone

      DIGESTIVE DISEASES AND SCIENCES
    72. Ostroff, RB; Nelson, JC
      Risperidone augmentation of selective serotonin reuptake inhibitors in major depression

      JOURNAL OF CLINICAL PSYCHIATRY
    73. Feighner, JP
      Mechanism of action of antidepressant medications

      JOURNAL OF CLINICAL PSYCHIATRY
    74. Feighner, JP
      Overview of antidepressants currently used to treat anxiety disorders

      JOURNAL OF CLINICAL PSYCHIATRY
    75. DeVane, CL; Pollock, BG
      Pharmacokinetic considerations of antidepressant use in the elderly

      JOURNAL OF CLINICAL PSYCHIATRY
    76. Thase, ME
      Antidepressant treatment of the depressed patient with insomnia

      JOURNAL OF CLINICAL PSYCHIATRY
    77. Burda, A; Webster, K; Leikin, JB; Chan, SB; Stokes, KA
      Nefazadone-induced acute dystonic reaction

      VETERINARY AND HUMAN TOXICOLOGY
    78. Cadieux, RJ
      Antidepressant drug interactions in the elderly - Understanding the P-450 system is half the battle in reducing risks

      POSTGRADUATE MEDICINE
    79. Laroudie, C; Salazar, DE; Cosson, JP; Cheuvart, B; Istin, B; Girault, J; Ingrand, I; Decourt, JP
      Pharmacokinetic evaluation of co-administration of nefazodone and lithium in healthy subjects

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    80. Rao, U; Poland, RE; Lutchmansingh, P; Ott, GE; McCracken, JT; Lim, KM
      Relationship between ethnicity and sleep patterns in normal controls: implications for psychopathology and treatment

      JOURNAL OF PSYCHIATRIC RESEARCH
    81. Fryer, JD; Lukas, RJ
      Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function

      JOURNAL OF NEUROCHEMISTRY
    82. Brotto, LA; Hanson, LA; Gorzalka, BB
      Nefazodone attenuates the stress-induced facilitation of wet dog shaking behaviour but not the facilitation of sexual behaviour in female rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    83. Rajagopalan, M; Little, J
      Discontinuation symptoms with nefazodone

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    84. Hickie, I
      Nefazodone for patients with chronic fatigue syndrome

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    85. von Moltke, LL; Greenblatt, DJ; Granda, BW; Grassi, JM; Schmider, J; Harmatz, JS; Shader, RI
      Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions

      PSYCHOPHARMACOLOGY
    86. YAO V; SHAH VR; SHYU WC; SRINIVAS NR
      SENSITIVE LIQUID-CHROMATOGRAPHIC MASS-SPECTROMETRIC ASSAY FOR THE SIMULTANEOUS QUANTITATION OF NEFAZODONE AND ITS METABOLITES HYDROXYNEFAZODONE M-CHLOROPHENYLPIPERAZINE AND TRIAZOLE-DIONE IN HUMAN PLASMA USINGSINGLE-ION MONITORING

      Journal of chromatography B. Biomedical sciences and applications
    87. WEINER DM; LOWE FC
      PSYCHOTROPIC DRUG-INDUCED PRIAPISM - INCIDENCE, MECHANISM AND MANAGEMENT

      CNS DRUGS
    88. OLAUSSON P; ERICSON M; PETERSSON A; KOSOWSKI A; SODERPALM B; ENGEL JA
      NEFAZODONE ATTENUATES THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF ETHANOL

      Alcohol
    89. JURIMAROMET M; WRIGHT M; NEIGH S
      TERFENADINE-ANTIDEPRESSANT INTERACTIONS - AN IN-VITRO INHIBITION STUDY USING HUMAN LIVER-MICROSOMES

      British journal of clinical pharmacology
    90. VELLA JP; SAYEGH MH
      INTERACTIONS BETWEEN CYCLOSPORINE AND NEWER ANTIDEPRESSANT MEDICATIONS

      American journal of kidney diseases
    91. DAVIDSON JRT; WEISLER RH; MALIK ML; CONNOR KM
      TREATMENT OF POSTTRAUMATIC-STRESS-DISORDER WITH NEFAZODONE

      International clinical psychopharmacology
    92. MONTGOMERY SA; KASPER S
      SIDE-EFFECTS, DROPOUTS FROM TREATMENT AND COST CONSEQUENCES

      International clinical psychopharmacology
    93. Horst, WD; Preskorn, SH
      Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion

      JOURNAL OF AFFECTIVE DISORDERS
    94. VOGEL G; COHEN J; MULLIS D; KENSLER T; KAPLITA S
      NEFAZODONE AND REM-SLEEP - HOW DO ANTIDEPRESSANT DRUGS DECREASE REM-SLEEP

      Sleep
    95. DeVane, CL
      Differential pharmacology of newer antidepressants

      JOURNAL OF CLINICAL PSYCHIATRY
    96. LONGO LP; JOHNSON B
      TREATMENT OF INSOMNIA IN SUBSTANCE-ABUSING PATIENTS

      Psychiatric annals
    97. KHOUZAM HR; MONTEIRO AJ; GERKEN ME
      REMISSION OF CANCER CHEMOTHERAPY-INDUCED EMESIS DURING ANTIDEPRESSANTTHERAPY WITH NEFAZODONE

      Psychosomatic medicine
    98. HANSON LA; GORZALKA BB; BROTTO LA
      THE ANTIDEPRESSANT, NEFAZODONE, ATTENUATES CORTICOSTERONE-INDUCED INCREASES IN 5-HT2A RECEPTOR-MEDIATED BEHAVIORS IN THE FEMALE RAT

      European journal of pharmacology
    99. Nacca, A; Guiso, G; Fracasso, C; Cervo, L; Caccia, S
      Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents

      BRITISH JOURNAL OF PHARMACOLOGY
    100. ROTZINGER S; FANG J; COUTTS RT; BAKER GB
      HUMAN CYP2D6 AND METABOLISM OF M-CHLOROPHENYLPIPERAZINE

      Biological psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 12:20:02